Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIFE: Inflammatory Challenge and Fear Extinction in PTSD
NCT06630884Phase 1Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Mar 2025
- Primary completion
- Nov 2028
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing Polysaccharide typhoid vaccine with Saline Placebo Arm (2 arms). Primary endpoint: Skin conductance response at 1 week. Started Mar 2025; status: recruiting.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
Beyond the preview
Go deeper on NCT06630884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06630884.